2015
DOI: 10.17511/ijmrr.2015.1.019
|View full text |Cite
|
Sign up to set email alerts
|

Vulvovaginal Candidiasis and its Antifungal Susceptibility Pattern: Single center experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…The study done by Mbakwem-Aniebo et al shows that the VC is more prevalent in the age group of 20-29 years which is also complementary to the findings of the present study [24]. The study carried out by Rati et al [25] and James et al [26] also states that the vulvovaginal candidiasis is more prevalent in the age group 20-29 years which resembles to the present study.…”
Section: Discussionsupporting
confidence: 89%
“…The study done by Mbakwem-Aniebo et al shows that the VC is more prevalent in the age group of 20-29 years which is also complementary to the findings of the present study [24]. The study carried out by Rati et al [25] and James et al [26] also states that the vulvovaginal candidiasis is more prevalent in the age group 20-29 years which resembles to the present study.…”
Section: Discussionsupporting
confidence: 89%
“…However, this was not statistically significant (p = 0.653; p > 0.05). The highest frequency of VVC in pregnant women in the same age groups was reported by Rati et al [36] and Damen et al [17]. Although the association was not statistically significant, the majority of the VVC confirmed participants were in their third trimester [6][7][8] and had only basic education.…”
Section: Discussionmentioning
confidence: 77%
“…Antifungal susceptibility testing was performed on Mueller-Hinton (MH) agar (Oxoid Ltd., England) supplemented with 2% glucose and 0.5 μg/ml methylene blue by disk diffusion method for nystatin (100 μg), fluconazole (25 μg) and voriconazole (1 μg) disks (Oxoid Ltd., England) [31,32]. Using a sterile inoculating loop, an inoculum was prepared using distinct colonies of Candida isolates from the SDA plates which were transferred into a 5 ml test tube containing 0.85% sterile saline solution, and emulsified to form a suspension of turbidity equivalent to 0.5 McFarland standard as compared to a 0.5 McF PhoenixSpec Calibrator (Becton, Dickinson and Company, USA).…”
Section: Laboratory Test Processesmentioning
confidence: 99%
“…Antifungal susceptibility testing of fluconazole (25 μg) was carried out by disc diffusion on Mueller-Hinton (MH) agar method as described by [ 31 ] with slight modifications. Briefly, with a sterile inoculating loop, an inoculum was prepared using distinct colonies of C .…”
Section: Methodsmentioning
confidence: 99%